In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6528
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits ; volume:7 ; number:1 ; day:14 ; month:5 ; year:2018 ; pages:157-165 ; date:6.2018
Ophthalmology and therapy ; 7, Heft 1 (14.5.2018), 157-165, 6.2018
- Urheber
-
Sheppard, John D.
- Beteiligte Personen und Organisationen
-
Cockrum, Paul C.
Justice, Angela
Jasek, Mark C.
SpringerLink (Online service)
- DOI
-
10.1007/s40123-018-0130-1
- URN
-
urn:nbn:de:101:1-2018082111563462416890
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sheppard, John D.
- Cockrum, Paul C.
- Justice, Angela
- Jasek, Mark C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
Lotilaner Ophthalmic Solution 0.25%: First Approval
Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval
Ophthalmic histopathology
Ophthalmic histopathology
Practical ophthalmic microsurgery
Ophthalmic surgical procedures
Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates
The physical, chemical, and microbiological stability of chloramphenicol ophthalmic solution
Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose
Viscoelastics in ophthalmic surgery
Correction to: In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
Lotilaner Ophthalmic Solution 0.25%: First Approval
Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval
Ophthalmic histopathology
Ophthalmic histopathology
Practical ophthalmic microsurgery
Ophthalmic surgical procedures
Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates
The physical, chemical, and microbiological stability of chloramphenicol ophthalmic solution
Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose
Viscoelastics in ophthalmic surgery
Correction to: In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
Lotilaner Ophthalmic Solution 0.25%: First Approval
Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval
Ophthalmic histopathology
Ophthalmic histopathology
Practical ophthalmic microsurgery
Ophthalmic surgical procedures
Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates
The physical, chemical, and microbiological stability of chloramphenicol ophthalmic solution
Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose